Crossmark

Promoting quality use of medicines in South-East Asia: reports from country situational analyses

Crossref DOI link: https://doi.org/10.1186/s12913-018-3333-1

Published Online: 2018-07-05

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Holloway, Kathleen Anne http://orcid.org/0000-0001-5032-6357
Kotwani, Anita

Batmanabane, Gitanjali

Santoso, Budiono

Ratanawijitrasin, Sauwakon

Henry, David
License Information

Text and Data Mining valid from 2018-07-05
More Information

Article History

Received: 15 February 2018

Accepted: 26 June 2018

First Online: 5 July 2018

Ethics approval and consent to participate

: All the data used in this study was obtained from published country reports of situational analyses of medicines management - all of which are publicly available online at: ExternalRef removed and ExternalRef removedAll administrative permissions, including formal approval by the respective Ministry’s of Health were obtained, prior to publication of the country reports on the WHO/SEARO website, as mandated by the World Health Organisation’s Regional Committee Resolution SEA/RC66/R7, Effective Management of Medicine, World Health Organization Regional Office for South-East Asia, New Delhi, 2013 (see reference [CitationRef removed]). Furthermore, various data from these country reports have already been extracted, analysed, and published on the WHO/SEARO website and internationally (see reference [CitationRef removed]).

: Not Applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.